from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2280/-

LFCtreatmentdescriptionclass of inhibitor

-0.964

Amikacinug/mL Amikacintranslation

-0.552

Cap5-10ug/mL Capreomycintranslation

-0.171

Rox10-50 ug/mL Roxithromycintranslation

-0.077

SM2-5 ug/mL Streptomycintranslation

-2.246

Tet5-10 ug/mL Tetracyclinetranslation

-1.025

Rif0.2-5ug/mL Rifampicintranscription

-0.713

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.532

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.946

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.721

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.645

Clofazimine10-13 ug/mL Clofaziminerespiration

0.109

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.573

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.968

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.215

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.379

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.681

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.186

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.110

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.071

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.436

KCN5-20 ug/mL Potassium cyaniderespiration

1.333

NaN30.2-2 mM Sodium aziderespiration

0.446

Nigericin50 uM Nigericinrespiration

-0.870

TRC10-150 ug/mL Triclosanrespiration

0.286

TRZ10-25 ug/mL Thioridazinerespiration

-0.036

Valinomycin0.5-10 uM Valinomycinrespiration

0.746

ZnSO42 mM ZnSO4respiration

0.140

menadione6-10 ug/mL Menadionerespiration

-1.019

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.356

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.723

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.491

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.150

NRP_1Non-replicating persistence stage 1dosRassociated

-0.593

Amp0.2mg/mL AmpicillincellWall

-0.274

Cephalexin20-100 ug/mL CephalexincellWall

-0.330

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.317

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.468

EMB10-20 ug/mL EthambutolcellWall

0.315

Eta12-40 ug/mL EthionamidecellWall

0.064

INH0.2-0.4 ug/mL IsoniazidcellWall

0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.327

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.091

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.913

BZA0.12 mg/mL BenzamidearomaticAmides

1.542

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.731

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.039

H2O24 mM hydrogen peroxideDNAdamaging

-1.111

Levo10 ug/mL LevofloxacinDNAdamaging

-0.088

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.095

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.424

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.064

UVUV-irradiationDNAdamaging

-1.300

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.322

Antimycin12.5-50 ug/mL Antimycin A?

-0.169

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.298

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.014

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.044

PA8240.2-2 ug/mL PA-824?

0.617

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.027

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.585

Verapamil50 uM Verapamil?

-0.077

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.651

methoxatin10-20 ug/mL Methoxatin?